Featured Research

from universities, journals, and other organizations

Vaccine Kills Spreading Cancer In Animal Model

Date:
June 2, 1998
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins scientists have developed a vaccine that, in mice, can alert the immune system to the presence of stray cancer cells and significantly reduce their blood-borne spread.

Johns Hopkins scientists have developed a vaccine that, in mice, can alert the immune system to the presence of stray cancer cells and significantly reduce their blood-borne spread.

"Metastatic cancer, or cancer that is spreading from its site of origin, is among the toughest stages of cancer to treat," says Hongxiu Ji, M.D., postdoctoral fellow. "Our findings suggest cancer vaccines could be an important tool for preventing and treating the spread of cancers."

Giving the vaccine prior to a tail vein injection of cancer cells prevented development of metastatic lung tumors in eight of 10 mice, while all the mice in two control groups that received cancer cells but no vaccine developed tumors. A second test against established lung cancer showed that the vaccine completely eliminated tumors in 50 percent of mice.

Ji presents her results, funded by the National Institutes of Health and the Richard W. TeLinde endowment, at this week's meeting of the American Society of Gene Therapy in Seattle.

The vaccine takes advantage of a protein, E7, produced by the human papilloma virus and commonly found in cervical cancers and their metastatic cancers. To make the vaccine, scientists altered vaccinia, a common virus, to include a gene for E7 and a molecular signal. The vaccine infects cells in the body, causing them to make E7, and the molecular signal triggers a chain reaction that calls E7 to the immune system's attention. This leads to an immune system attack on all cells that contain the protein--including the cancer cells.

To test whether the vaccine is effective against metastatic cervical cancer, Ji and her colleagues developed a line of tumor cells by genetically altering mouse lung cells to include E7. This made the cells similar to cervical cancer cells. She then showed that a tail vein injection of the cancer cells could cause lung tumors in mice in two weeks.

Tests showed the vaccine could prevent this process in a significant portion of the mice tested and that it could eliminate already established lung tumors.

"Ji's results demonstrate the potency of the vaccine and give hope that immunotherapy may help us control metastatic cancers," says T.C. Wu, M.D., Ph.D., associate professor of pathology. "The strategy we've used to develop this vaccine can also be used for other virus-associated cancers and any cancer that expresses a unique protein not found elsewhere in the body."

The principle disadvantage to the current vaccine, Ji notes, is that it may not be possible to use a second time in the same patient. Researchers believe that one exposure will sensitize the immune system to vaccinia, leading it to sweep up a second dose before it can infect cells and start the chain reaction.

Scientists currently are working on new approaches to overcome this problem, including direct administration of the E7 gene with a gene gun, so-called "naked" DNA vaccination. Plans also are being made for an initial human trial of the current vaccine.

Other study authors were Wu, Edwin Chang, Ken-Yu Lin, Robert Kurman, and Drew Pardoll.

--JHMI--

Johns Hopkins Medical Institutions' news releases are available on a PRE-EMBARGOED basis on EurekAlert at http://www.eurekalert.org, Newswise at http://www.newswise.com and from the Office of Communications and Public Affairs' direct e-mail news release service. To enroll, call 410-955-4288 or send e-mail to bsimpkin@welchlink.welch.jhu.edu or 76520.560@compuserve.com.

On a POST-EMBARGOED basis find them at http://hopkins.med.jhu.edu, Quadnet at http://www.quad-net.com, ScienceDaily at http://www.sciencedaily.com or on CompuServe in the SciNews-MedNews library of the Journalism Forum under file extension ".jhm".


Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Vaccine Kills Spreading Cancer In Animal Model." ScienceDaily. ScienceDaily, 2 June 1998. <www.sciencedaily.com/releases/1998/06/980602162120.htm>.
Johns Hopkins Medical Institutions. (1998, June 2). Vaccine Kills Spreading Cancer In Animal Model. ScienceDaily. Retrieved September 17, 2014 from www.sciencedaily.com/releases/1998/06/980602162120.htm
Johns Hopkins Medical Institutions. "Vaccine Kills Spreading Cancer In Animal Model." ScienceDaily. www.sciencedaily.com/releases/1998/06/980602162120.htm (accessed September 17, 2014).

Share This



More Health & Medicine News

Wednesday, September 17, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

President To Send 3,000 Military Personnel To Fight Ebola

President To Send 3,000 Military Personnel To Fight Ebola

Newsy (Sep. 16, 2014) President Obama is expected to send 3,000 troops to West Africa as part of the effort to contain Ebola's spread. Video provided by Newsy
Powered by NewsLook.com
Man Floats for 31 Hours in Gulf Waters

Man Floats for 31 Hours in Gulf Waters

AP (Sep. 16, 2014) A Texas man is lucky to be alive after he and three others floated for more than a day in the Gulf of Mexico when their boat sank during a fishing trip. (Sept. 16) Video provided by AP
Powered by NewsLook.com
Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

Ivorians Abandon Monkey Pets in Fear Over Ebola Virus

AFP (Sep. 16, 2014) Since the arrival of Ebola in Ivory Coast, Ivorians have been abandoning their pets, particularly monkeys, in the fear that they may transmit the virus. Duration: 00:47 Video provided by AFP
Powered by NewsLook.com
Study Links Male-Pattern Baldness To Prostate Cancer

Study Links Male-Pattern Baldness To Prostate Cancer

Newsy (Sep. 16, 2014) New findings suggest men with a certain type of baldness at age 45 are 39 percent more likely to develop aggressive prostate cancer. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

      Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins